Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.
暂无分享,去创建一个
[1] T. Liesegang. Intracameral antibiotics: questions for the United States based on prospective studies. , 2008, Journal of cataract and refractive surgery.
[2] T. O'brien,et al. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin , 2007, Journal of cataract and refractive surgery.
[3] S. Masket,et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2007 ASCRS member survey , 2007, Journal of cataract and refractive surgery.
[4] A. M. Thompson. Ocular toxicity of fluoroquinolones , 2007, Clinical & experimental ophthalmology.
[5] U. Stenevi,et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. , 2007, Ophthalmology.
[6] V. Caparas,et al. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients , 2007, Journal of cataract and refractive surgery.
[7] Daniel G Dawson,et al. Toxic anterior segment syndrome. , 2006, Journal of cataract and refractive surgery.
[8] W. Mieler,et al. Clearance of intravitreal moxifloxacin. , 2006, Investigative ophthalmology & visual science.
[9] S. Seregard,et al. Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. , 2005, The Journal of hospital infection.
[10] E. Romanowski,et al. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. , 2005, American journal of ophthalmology.
[11] J. Alió,et al. Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. , 2005, Journal of cataract and refractive surgery.
[12] D. Hwang. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. , 2004, Survey of ophthalmology.
[13] R. Tipperman. Pharmacologic considerations for cataract surgery , 2004, Current opinion in ophthalmology.
[14] U. Pleyer,et al. Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes , 2004, International Ophthalmology.
[15] N. Chin,et al. Intracameral antibiotic agents for endophthalmitis prophylaxis: A pharmacokinetic model , 2003, Journal of cataract and refractive surgery.
[16] F. Mah. New antibiotics for bacterial infections. , 2003, Ophthalmology clinics of North America.
[17] W. Green,et al. Ocular toxicity of intravitreal trovafloxacin in the pigmented rabbit , 2003, Current eye research.
[18] G. Koranyi,et al. Prophylactic intracameral cefuroxime: Efficacy in preventing endophthalmitis after cataract surgery , 2002, Journal of cataract and refractive surgery.
[19] C. Zetterström,et al. Prophylactic intracameral cefuroxime: Evaluation of safety and kinetics in cataract surgery , 2002, Journal of cataract and refractive surgery.
[20] H. Edelhauser,et al. Effect of indocyanine green intraocular stain on human and rabbit corneal endothelial structure and viability: An in vitro study , 2002, Journal of cataract and refractive surgery.
[21] G. Doern. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] A. M. Berrocal,et al. Subconjunctival cephalosporin anaphylaxis. , 2001, Ophthalmic surgery and lasers.
[23] D. Weinberger,et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. , 1999, Ophthalmology.
[24] T. Riordan,et al. The effect of intracameral, per-operative antibiotics on microbial contamination of anterior chamber aspirates during phacoemulsification , 1998, Eye.
[25] A. Dublanchet,et al. Vancomycin prophylaxis and intraocular contamination during cataract surgery , 1997, Journal of cataract and refractive surgery.
[26] W. Tasman,et al. Postoperative endophthalmitis in association with diabetes mellitus. , 1994, Ophthalmology.
[27] S. Stevens,et al. Intraocular safety of ciprofloxacin. , 1991, Archives of ophthalmology.
[28] G. Peyman,et al. Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. , 1991, Current eye research.
[29] M. Taylor,et al. Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction. , 1981, The British journal of ophthalmology.